Quince Therapeutics, Inc. (QNCX) — Financial Flexibility Index
Quince Therapeutics, Inc. (QNCX) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-7.62 Million (operating CF $-7.63 Million minus capex $4.00K) represents -1% of total liabilities ($10.95 Million). Check Quince Therapeutics, Inc. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quince Therapeutics, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Quince Therapeutics, Inc. across 9 annual periods. See QNCX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Quince Therapeutics, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Quince Therapeutics, Inc.. For the full company profile including market capitalisation, see QNCX market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-41.07 Million | $-41.42 Million | $129.24 Million | ▲ +15.3% |
| 2024 | -0.38x | $-31.65 Million | $-31.90 Million | $84.33 Million | ▼ -96.9% |
| 2023 | -0.19x | $-18.13 Million | $-18.29 Million | $95.12 Million | ▲ +98.6% |
| 2022 | -13.24x | $-43.91 Million | $-44.04 Million | $3.32 Million | ▼ -208.8% |
| 2021 | -4.29x | $-62.75 Million | $-62.93 Million | $14.64 Million | ▼ -45.2% |
| 2020 | -2.95x | $-50.77 Million | $-50.82 Million | $17.20 Million | ▲ +21.0% |
| 2019 | -3.74x | $-33.22 Million | $-33.28 Million | $8.89 Million | ▲ +52.6% |
| 2018 | -7.88x | $-11.48 Million | $-11.70 Million | $1.46 Million | ▼ -2163.2% |
| 2017 | -0.35x | $-9.75 Million | $-9.83 Million | $28.00 Million | — |